208.45 USD
▲-4.98+3.29%
盘后 213.49 0.00%
2026-07-31
市值
$30.80B
市盈率
36.97
EPS
5.64
股息率
—
52 周区间
124.56 – 219.72
成交量
1.21M
Beta
0.16
目标价
234.35
52W 低 124.5652W 高 219.72
价格走势
公司简介
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar refe...